Close
Novotech
Jabsco PureFlo 21 Single Use

News

Europe Pharma Manufacturing Not In Best Shape With PFAS Cut

The European Federation of Pharmaceutical Industries and Associations (EFPIA) recently warned that more than 600 essential medicines could be at risk if suggested limitations on the use of fluorinated substances, especially per- and polyfluoroalkyl substances- PFAS, in pharmaceutical manufacturing...

Sharp acquires Berkshire Sterile Manufacturing

Sharp, a global leader in commercial pharmaceutical packaging and clinical trial supply services, has announced the acquisition of Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish contract development and manufacturing organization (CDMO) for clinical and commercial sterile injectable products. The...

Paper & Digital Make Accessibility To Pharma Data Seamless

The proposal by the European Commission to re-examine the pharmaceutical legislation has ignited an extensive debate. The suggestion in the directive to offer Member States the option to choose among electronic as well as traditional paper medical leaflets builds upon valid worries when it comes to potentially eliminating...

Labelling Solutions Adding Speed & Precision In Drug Delivery

In recent years, there has been an increasing awareness of the importance when it comes to acting quickly and also being adaptable when it comes to the development and delivery of pharmaceutical products. The expedited trials for the COVID-19...

Upgraded Pharma Packaging Offered With AI-Led Spectroscopy

A paper published in the IEEE Sensors Journal has gone on to showcase an apt method for effectively verifying the content of pharmaceutical packaging with an accuracy rate that happens to be 100% that has been made possible by...

BioCity, AstraZeneca Partner on Treatment of Advanced HCC

BioCity Biopharma and AstraZeneca signed an agreement to collaborate on a Phase Ib/II clinical study to evaluate the safety and efficacy of BioCity's BC3402, a monoclonal antibody (mAb) targeting the T cell immunoglobulin and mucin domain-containing protein 3, also...

Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration

Quris-AI, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena announced the extension of its collaboration with Merck KGaA, Darmstadt, Germany, a leading science and technology company. This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »